Phosphodiesterase type 5 inhibitors in pulmonary hypertension: a Hobson's choice for Indian patients.

dc.contributor.authorSaxena, Anitaen_US
dc.date.accessioned2007-07-08en_US
dc.date.accessioned2009-05-27T04:29:09Z
dc.date.available2007-07-08en_US
dc.date.available2009-05-27T04:29:09Z
dc.date.issued2007-07-08en_US
dc.identifier.citationSaxena A. Phosphodiesterase type 5 inhibitors in pulmonary hypertension: a Hobson's choice for Indian patients. Indian Heart Journal. 2007 Jul-Aug; 59(4): 299-301en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/5797
dc.language.isoengen_US
dc.source.urihttps://indianheartjournal.comen_US
dc.subject.meshCarbolines --therapeutic useen_US
dc.subject.meshDisease Progressionen_US
dc.subject.meshHumansen_US
dc.subject.meshHypertension, Pulmonary --drug therapyen_US
dc.subject.meshIndia --epidemiologyen_US
dc.subject.meshPhosphodiesterase Inhibitors --therapeutic useen_US
dc.subject.meshPiperazines --therapeutic useen_US
dc.subject.meshPurines --therapeutic useen_US
dc.subject.meshSulfones --therapeutic useen_US
dc.titlePhosphodiesterase type 5 inhibitors in pulmonary hypertension: a Hobson's choice for Indian patients.en_US
dc.typeCommenten_US
dc.typeEditorialen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: